Daimon H, Sawada S, Asakura S, Sagami F
Drug Safety Research Laboratories, Eisai Co., Ltd., Hashima-gun, Gifu-ken, Japan.
Carcinogenesis. 1998 Jan;19(1):141-6. doi: 10.1093/carcin/19.1.141.
The induction of chromosome aberrations, sister chromatid exchanges (SCEs), and the formation of DNA adducts was studied in hepatocytes of F344 rats exposed in vivo to safrole. Hepatocytes were isolated 24 h after a single dose of safrole or five repeated doses (once a day) by gastric intubation and allowed to proliferate in Williams' medium E supplemented with epidermal growth factor. Cells were fixed after 48 h in culture. Safrole-DNA adducts were detected by a nuclease P1-enhanced 32P-post-labeling assay in isolated hepatocytes from the rats. While a single dose was not sufficient to induce detectable levels of chromosome aberrations at the time of assay, five repeated doses induced these changes with a maximum frequency of 13.4%, compared with the control value of 1.8%. Both a single dose and five repeated doses induced significant SCEs, to a maximum frequency of 0.81 SCEs per chromosome, while the control value was 0.59 SCEs per chromosome. Two major and two minor DNA adducts were detected after treatment with either a single dose or five repeated doses. The maximum amount of total DNA adducts was 89.8 DNA adducts/10(7) nucleotides. These results show that safrole is a genotoxic carcinogen in the rat liver in vivo and suggest that the cytogenetic effects of this compound may result from covalent DNA modification in the rat liver. This in vivo cytogenetic assay should provide a useful means of evaluation of the genotoxicity of hepatocarcinogens.
研究了体内暴露于黄樟素的F344大鼠肝细胞中染色体畸变、姐妹染色单体交换(SCE)及DNA加合物的形成情况。通过胃管单次给予黄樟素或五次重复给药(每天一次)后24小时分离肝细胞,并使其在补充有表皮生长因子的Williams培养基E中增殖。培养48小时后固定细胞。采用核酸酶P1增强的32P后标记分析法检测大鼠分离肝细胞中的黄樟素-DNA加合物。单次给药在检测时不足以诱导可检测水平的染色体畸变,而五次重复给药诱导这些变化的最大频率为13.4%,而对照值为1.8%。单次给药和五次重复给药均诱导了显著的SCE,最大频率为每条染色体0.81次SCE,而对照值为每条染色体0.59次SCE。单次给药或五次重复给药后均检测到两种主要和两种次要的DNA加合物。总DNA加合物的最大量为89.8个DNA加合物/10(7)个核苷酸。这些结果表明,黄樟素在体内对大鼠肝脏是一种遗传毒性致癌物,并提示该化合物的细胞遗传学效应可能源于大鼠肝脏中DNA的共价修饰。这种体内细胞遗传学检测应为评估肝癌致癌物的遗传毒性提供一种有用的方法。